Large Cap - Spark Newswire

2 minute read

Barron’s Latest Picks And Pans: Twitter, Tesla, Nielsen And A Struggling Exercise Equipment Company

Today, 1:15 PM

Benzinga reviews this weekend's top stories on Barron's, for additional information on the latest market news, Benzinga Pro offers a 24/7 news feed, live chat and charting software.

NLSN

1 minute read

Johnson & Johnson’s Baby Talc Litigation, Faces Fresh Claims It Hid Evidence: Bloomberg

By Vandana Singh

Today, 1:15 PM

Bloomberg first reported that U.S.

JNJ

1 minute read

Sanofi’s Rilzabrutinib Data In Autoimmune Blood Disorder Published In New England Journal of Medicine

By Vandana Singh

Today, 1:15 PM

Results from the Phase 1/2 dose-finding study evaluating Sanofi SA’s (NASDAQ:SNY) rilzabrutinib in adults with heavily pre-treated immune thrombocytopenia (ITP) were…

SNY

1 minute read

Bristol Myers’ Neoadjuvant Opdivo/Chemo Therapy Yet To Reach Overall Survival Endpoint In Early-Stage Lung Cancer

By Vandana Singh

Today, 1:15 PM

Bristol Myers Squibb Co (NYSE: BMY) announced results from the Phase 3 CheckMate -816 trial in resectable non-small cell lung cancer (NSCLC).

BMY

1 minute read

Eli Lilly Reveals More Phase 3 Data From Lebrikizumab Trial In Atopic Dermatitis

By Vandana Singh

Today, 1:15 PM

Eli Lilly And Co (NYSE: LLY)

LLY

1 minute read

Pfizer Beefs Up Its RSV Antiviral Portfolio With $525M ReViral Acquisition

By Vandana Singh

Today, 1:15 PM

Pfizer Inc (NYSE:PFE) has agreed to acquire ReViral Ltd, a privately held, clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing…

PFE

1 minute read

Merck Expands Elkton Manufacturing Facility To Boost HPV Vaccine Supply

By Vandana Singh

Today, 1:15 PM

Merck & Co Inc (NYSE: MRK) has invested in manufacturing and recently expanded its vaccines manufacturing facility in Elkton, VA.

MRK

1 minute read

See Why Did FDA Extend Review Period For Alnylam’s Vutrisiran In Amyloidosis

By Vandana Singh

Today, 1:15 PM

The FDA has extended the review timeline for Alnylam Pharmaceuticals Inc’s (NASDAQ:ALNY) marketing application for vutrisiran for transthyretin-mediated (ATTR) amyloidosis. The updated…

ALNY

1 minute read

FDA Grants Priority Review To Roche’s Actemra For Hospitalized COVID-19 Adults

By Vandana Singh

Today, 1:15 PM

The FDA has granted priority review to Roche Holdings AG’s (OTC:RHHBY) Actemra/RoActemra (tocilizumab) for COVID-19 in hospitalized adults. “If approved, Actemra/RoActemra would…

RHHBF

1 minute read

Novartis To Strengthen Pipeline, Boost Productivity With New Organizational Structure

By Vandana Singh

Today, 1:15 PM

Novartis AG (NYSE:NVS) will integrate its pharmaceuticals and oncology units into an innovative medicines (IM) business to simplify its structure, targeting…

NVS